PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-1.63%)
As of: Oct 1, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) Acquisitions (2011 - 2013)

Updated

PharmaCyte Biotech's Acquisitions came in at $51,215 for FY2014 (year ended Apr 30, 2014).

Analysis

PharmaCyte Biotech (PMCB) Acquisitions (2011 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -17.24 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -23.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.21 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 PharmaCyte Biotech 4.40 Mn 4.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2013 -1.52 Mn
Jul 31, 2013 1.57 Mn
Apr 30, 2013 -481,750.00
Jan 31, 2013 160,000.00
Jan 31, 2012 -120,000.00
Oct 31, 2011 -240,000.00
Jul 31, 2011 -320,000.00
API Access

PharmaCyte Biotech Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=PMCB&period=max&api_key=YOUR_API_KEY